GSA Capital Partners’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-87,465
Closed -$40K 2235
2026
Q1
$40K Sell
87,465
-101,711
-54% -$93.8K ﹤0.01% 1619
2025
Q4
$416K Buy
189,176
+10,153
+6% +$16.3K 0.04% 944
2025
Q3
$285K Buy
+179,023
New +$232K 0.02% 1233

Other funds holding GUTS

GSA Capital Partners's GUTS Position: Q2 2026 in Review

GSA Capital Partners sold out of Fractyl Health (GUTS) in Q2 2026, closing a stake of 87,465 shares — an estimated $40K sold.

GSA Capital Partners first reported a position in GUTS in Q3 2025 and held it in 3 quarters. The position peaked at $416K in Q4 2025. 77 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.

  • GSA Capital Partners reported no remaining Fractyl Health position as of Q2 2026 after selling out during the quarter.
  • GSA Capital Partners sold 87,465 Fractyl Health shares in Q2 2026, an estimated $40K.
  • GSA Capital Partners first reported a position in Fractyl Health in Q3 2025 and held it in 3 quarters.
  • GSA Capital Partners's Fractyl Health position peaked at $416K in Q4 2025.
  • 77 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.